From Insight to Impact: Strategic Growth Mapping in the Point-of-Care (POC) Coagulation Testing Market

Global Medical Device Connectivity Market

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#What Are the Key Projections for the CAGR of the Point-of-Care (POC) Coagulation Testing Market Size From 2025 to 2034?#_x000D_

Recent years have seen a robust expansion in the market size of point-of-care (POC) coagulation testing. The industry is projected to keep this momentum with an increase of market size from $1.18 billion in 2024 to $1.25 billion in 2025, growing at a compound annual growth rate (CAGR) of 5.4%. The growth during the historic period was driven by several factors including increase in patient demand, a rising trend in POC testing, the high dependability of coagulation status on PT test, the infusion of automation and integration with electronic health records (EHRs), and an increasing prevalence of cardiovascular diseases and blood-related disorders._x000D_

_x000D_

Consistent growth is projected for the point-of-care (poc) coagulation testing market in the coming years. The market is anticipated to reach $1.47 billion in 2029, with a 4.2% compound annual growth rate (CAGR). The push factors for this growth across the forecast period include enlarged application in the health sector, surged demand within homecare scenarios, a rising incidence of chronic blood illnesses, patient preference for swift and accurate tests, in addition to the growth of point-of-care testing. Key trends within this period encompass technological progression, high demand from developed nations, broadening use in healthcare, COVID-19 ramifications, and the growing trend of multiplexing POC diagnostics._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=13913&type=smp_x000D_

_x000D_

#What are the Fundamental Drivers and Innovations Shaping the Point-of-Care (POC) Coagulation Testing Market?#_x000D_

The proliferation of cardiovascular diseases is anticipated to bolster the expansion of the point-of-care (POC) coagulation testing market. Cardiovascular diseases (CVDs) encompass a variety of heart and blood vessel disorders, which include conditions like coronary heart disease, cerebrovascular disease, and peripheral arterial disease. POC coagulation assessments play a crucial role in treating CVDs, offering instantaneous data on coagulation status. This aids in making quick decisions regarding coagulation procedures, thereby minimizing the probability of hemorrhagic complications post cardiac surgery. As an example, a report published by the World Heart Federation, a Switzerland-based NGO, in October 2022 predicts a surge in CVD-related mortality. The number of deaths tied to CVD is projected to escalate from roughly 18.9 million in 2020 to over 22.2 million by 2030, eventually reaching 32.3 million by 2050. Therefore, the escalating occurrence of cardiovascular diseases is steering the expansion of the point-of-care (POC) coagulation testing market._x000D_

_x000D_

#How Is the Point-of-Care (POC) Coagulation Testing Market Segmented?#_x000D_

The point-of-care (poc) coagulation testingmarket covered in this report is segmented – _x000D_

_x000D_

1) By Technology: Optical Technology, Mechanical Technology, Electrochemical Technology_x000D_

2) By Distribution Channel: Direct Tenders, Retail_x000D_

3) By End-User: Hospitals, Clinics, Home care_x000D_

_x000D_

Subsegments:_x000D_

1) By Optical Technology: Reflectance Photometry, Fluorescence Detection, Colorimetric Detection_x000D_

2) By Mechanical Technology: Mechanical Oscillation, Ultrasonic Detection_x000D_

3) By Electrochemical Technology: Amperometric Detection, Potentiometric Detection, Conductometric Detection_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=13913&type=smp_x000D_

_x000D_

#Which Regions Are Driving the Next Phase of the Point-of-Care (POC) Coagulation Testing Market Growth?#_x000D_

North America was the largest region in the point-of-care (POC) coagulation testing market in 2024. The regions covered in the point-of-care (POC) coagulation testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#What Key Trends Are Shaping the Future of the Point-of-Care (POC) Coagulation Testing Market?#_x000D_

Major companies in the point-of-care (POC) coagulation testing marketplace are turning to strategic partnerships as a means to secure a strong market position. Such partnerships involve formal agreements in which two or more entities align to accomplish predetermined, mutually beneficial objectives. An excellent example of this is the collaboration between Jana care, a U.S based firm specializing in the development of biomarker assays for its proprietary digital health platform, and Roche Diagnostics, a Switzerland-based firm involved in developing diagnostic tests, tools, and digital solutions with the potential to revolutionize healthcare. Initiated in January 2023, this partnership focuses on the co-creation and distribution of a point-of-care blood testing system designed to screen for chronic kidney disease and heart failure. Envisioned as an innovative platform, it allows patients to conduct blood tests at home while clinicians review the results remotely._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/point-of-care-poc-coagulation-testing-global-market-report_x000D_

_x000D_

#How Is the Point-of-Care (POC) Coagulation Testing Market Defined and What Are Its Core Parameters?#_x000D_

Point-of-care (POC) coagulation testing refers to diagnostic tests that assess blood clotting function performed at the patient’s bedside or near the site of care, rather than in a centralized laboratory. It is used to provide real-time or near-real-time results (within minutes), significantly faster than traditional lab tests, that allow healthcare professionals to make quicker treatment decisions and optimize anticoagulation therapy._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13913_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model